Submit an IND application for CFT8634

Deadline passed; outcome being checked

What the company said

“Submit an IND application for CFT8634 in 2H 2021.”

SourceC4 Therapeutics, Inc. Form 8-K press release, 2021-01-06
FilingSEC filing index
Deadline as stated2H 2021
Deadline used31 Dec 2021, the last day of the stated period
TypeRegulatory
Permanent referenceKI-C-2021-CCCC-021181
Cite as https://keptindex.org/c/KI-C-2021-CCCC-021181/ — this address never changes.

The deadline has passed. We check for public evidence starting 30 days after the deadline, and repeat the check if nothing clear turns up.

Every time the company restated this commitment. The original is never changed, and the outcome is always measured against version 1.

Version 1 · original · stated 6 Jan 2021

Deadline 31 Dec 2021 (“2H 2021”)
Version 2 · stated 12 Jan 2021

Deadline 31 Dec 2021 (“2H 2021”) · wording expected

“IND Submission for CFT8634 Expected in 2H 2021”
Source for this version

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

This deadline has not been settled yet. We check 30 days after it passes. Get an email when we record the outcome.

Commitment recordedThe company's words were matched word for word against the filing.
OutcomeNot yet assessed. Nothing is judged before the deadline.

Are you C4 Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.